Results 241 to 250 of about 422,600 (405)

The burden of COVID-19 on pharmacists

open access: yesJournal of the American Pharmacists Association, 2020
K. Johnston   +3 more
semanticscholar   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

open access: yesMolecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon   +13 more
wiley   +1 more source

An Observational Study of Nicotine Replacement Therapy Availability Through Pharmacist Prescribing in the California Central Valley. [PDF]

open access: yesTob Use Insights
Halliday DM   +6 more
europepmc   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

open access: yesMolecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková   +14 more
wiley   +1 more source

Outcome Analysis of a Pharmacist‐Managed Anticoagulation Service [PDF]

open access: bronze, 1995
Vickie M. Wilt   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy